8-K: The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
8-K: Current report
8-K: Current report
8-K: The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
DEFA14A: Others
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
The Oncology Institute | 8-K: The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
The Oncology Institute | 8-K: Current report
The Oncology Institute | 8-K: Current report
The Oncology Institute | DEFA14A: Others
The Oncology Institute | 8-K/A: Current report (Amendment)
No Data